chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a female who was vaccinated with 2 doses of MMR II but was non immune when attempting to go to college. Titers were tested, result not reported. It was unknown if the patient sought medical attention. At the time of the reporting, the patient's status was unknown. Additional information has been requested.
Sudden death occured on 3/12/2008. 9/4/08-records received-Cause of Death:cardiovascular collapse as a consequence of pulmonary emboli, dehydration and diabetic ketacidosis.
This spontaneous report was received from a certified medical assistant and refers to a 10 week old, female patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 25-APR-2016 at 18:27, the patient was vaccinated with improperly stored first dose of ROTATEQ lot# L033543, expiry date 30-MAY-2017, orally (dose was not reported). No adverse symptoms were reported. The patient had no illness at the time of vaccination. Administered vaccine experienced temperature excursion of 34 degrees Fahrenheit for a total of 65 hours. There was no previous temperature excursion. Digital data logger was not involved. This is one of several reports received from the same source. Additional information is not expected, as all scheduled correspondence was received.
18AUG92 onset 5PM local reaction lt leg; t99.8 ax; slept 8PM 10AM; APAP given-19AUG92 12 noon mom noticed redness legs; local reaction rt thigh-redness;
joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days; joint inflammation leading to severe joint inflammation and swelling for 12 wks/5 days; extreme hairloss; hemoglobin leakage under skin; intermittent fever; intermittent body rash; extreme itching and/or burning of skin; burning of skin; Fatigue; severe allergic response to foods, histamine and any sugar; severe reaction to bee sting and amoxicillin; severe reaction to bee sting and amoxicillin; severe allergic response to foods, histamine and any sugar; This is a spontaneous report from a contactable nurse, the patient. A 69-year-old female patient received BNT162B2 (Lot EL3248, first dose) solution for injection intramuscular in left arm on 14Jan2021 at 12:15 (at the age of 69-years-old) as a single dose for COVID-19 immunization, amoxicillin, and histamine. The patient was not pregnant at the time of vaccination. Medical history included Previous Br CA (breast cancer) from 1993. Concomitant medication included losartan potassium/ hydrochlorothiazide. On 19Jan2021 at 12:00, the patient experienced joint inflammation leading to severe joint inflammation and swelling for 12 weeks/5days then extreme hair loss, hemoglobin leakage under skin, intermittent fever, intermittent body rash, extreme itching and/or burning of skin, fatigue, severe allergic response to foods, histamine and any sugar, severe reaction to bee sting and amoxicillin, severe reaction to bee sting and amoxicillin. The events resulted in doctor or other healthcare professional office/clinic visit. Lab tests included ultrasound lower extremities in 2021 with unknown results; COVID test type: Blood test on 28-SEP-2021 was positive covid_test_name_post_vaccination=previous covid and Negative covid test name post vaccination=to R/O other things (case 202101365226). The action taken with amoxicillin and histamines in response to the events was unknown. Treatment for the events included steroids and many office visits. The outcome of the events was not recovered. The patient received second dose of BNT162B2 on 10Feb2021 at 12:00 PM.; Sender's Comments: Based on the information currently available,The casual association between the reported event and suspected vaccine BNT162B2 cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Extreme weakness, severe headache, could not lift head up due to headache.  Also, needed a cane to walk due to complete weakness.  No treatment given and recovered by Sunday.
Patient presented with a swollen, painful arm.  Difficulty moving arm upwards.  Patient was seen by PCP and given a prescription for cephalexin.  All of this was done on 8/17/2023.
Patient complains of pain and numbness upon touch to injection site.  Has full movement.  No other S/S.  Has not sought out care.
Rash at site of injection occurred 3 days after immunization. Rash consisted of 1-2mm papular skin spread from site of immunization down leg next day to outer leg by knee. No itchiness.
pt recvd flu vax & devel redness & warmth @ inject site for 3 days; pt then exp itching for 3 days;
This case was reported by a healthcare professional and described the occurrence of low grade fever in a 1-year-old female subject who was vaccinated with HAVRIX 1440, (GlaxoSmithKline), MMR vaccine, VARICELLA vaccine, PREVNAR.  There were no concurrent medications.  On 19 March 2008 the subject received 1st dose of HAVRIX 1440 (unknown, left arm), 1st dose of MMR vaccine (unknown, left arm), 1st dose of VARICELLA vaccine (unknown), 4th dose of PREVNAR (unknown).  On 19 March 2008, in the afternoon, the subject experienced inappropriate dose of vaccine administered since the child received an adult dose of HAVRIX.  On an unspecified date, at an unspecified time after vaccination with HAVRIX 1440, MMR vaccine, PREVNAR and VARICELLA vaccine, the subject experienced low grade fever and loss of appetite.  The low grade fever was diagnosed by touch not by thermometer.  Medical attention was in the form of a phone conversation with a nurse.  At the time of reporting the outcome of the events of low grade fever and loss of appetite was unspecified.  The healthcare professional considered the events of low grade fever and loss of appetite were possibly related to vaccination with HAVRIX 1440, MMR vaccine, VARICELLA vaccine and PREVNAR.  Follow-up information received on 29 April 2008, via healthcare professional, who reported the outcome of the events continued to be unknown.
DEVELOPED 4 YELLOW SPOTS ON LEFT ARM AND 1 YELLOW SPOT ON RIGHT ARM UNDER IMMUNIZATION LOCATION.
I am a Physician Assistant in Cardiology/Critical Care Medicine and have been for 18 Years.  Roughly 1 month after my 2nd vaccination, I have developed diffuse (legs, arms, neck, shoulders) small pinpoint, erythematous, pruritic lesions. Total of 24.  My detergent, hygiene supplies, food, environment, pets and interactions are 100% unchanged.  As a colleague of mine developed a macular papular rash that was extremely uncomfortable and now I am having these lesions, I felt it was appropriate to report, in the event "this is a reaction to the COVID vaccine".
Patient with seizure disorder, hx of recurrent febrile seizures, 1st seizure of life after Hep A on 8/19/08. Other seizures since. Received KINRIX/PROQUAD/PREVNAR 13 -> developed redness at injection site, urticaria, generalized tonic-clonic seizure x 30-45 min.
PATIENT ARRIVED AT PHARMACY FEELING DIZZY, LIGHTHEADED AND ITCHYNESS ON FACE.  NO TROUBLE BREATHING. SLIGHTLY IN PANICKED STATE.  HE WAS DRIVING FROM A store ON THE WAY HOME AFTER RECEVING HIS VACCINATION WHEN HE EXPERIENCED THESE SYMPTOMS. STOPPED BY OUR store AFTER FEELING LIKE HE MAY PASS OUT FROM DIZZINESS. IMMEDIATELY HAD PATIENT SIT DOWN AND ADMINISTERED BENADRYL 50MG AFTER CHECKING  PATIENT WAS ABLE TO BREATHE, SWALLOW, AND TALK. MONITORED PATIENT FOR THE NEXT 30 MINUTES UNTIL HE CLAIMED HE FELT MUCH BETTER AND WANTED TO DRIVE HOME. OFFERED TO CALL 911 WHEN HE SAT BUT PATIENT REFUSED. COUNSELED PATIENT ON DROWSINESS FROM BENADRYL AND THAT IT MAY WEAR OFF LATER.
5 days after the administration of the vaccine I began to have a slight headache for 2 days. I then became ill with a flu like illness with chills and fever and had to go to bed for 4 or 5 days. I called my doctor and told him I had the flu he tested me for A and B flu and Covid 19 test and I was negative for them all. He suspected I had an adverse reaction to the vaccine. I was quite sick. I was bed bound. I didn't feel well for a total of 2 weeks.
Bell's Palsy... classic symptoms... numbness, drooping, nerve/muscular weakness on right side of face. Hospital visit after 36 hours of first signs.  Given diagnosis then immediately began taking Anti-viral medication (Acyclovir 800mg 5x daily for 7 days), Steroid (Prednisone 20mg  3-3, 2-3,1-3 / 9days), eye gel nightly for dry eye that won't blink or close correctly
The patient received two series of the Moderna vaccine at age 16. On 3/20/21 at Facility and on 4/24/21 at Facility. Should have received the Pfizer vaccine.
I woke up my arm was aching and kind of swollen. I also had a dry cough and dry throat. I am just getting over the dryness. March the 4th I went told the doctor about it...the doctor told me to give it a while, Nexium esomeprazole.  March 17 went to another doctor that I still had dry cough and post nasal drip. Fluticasone Propionate and Flonase and now I no longer have dry throat and the cough has calmed down.
light headiness; chills; fever; tired; loss of appetite; still very weak; This is a spontaneous report from a contactable consumer. This consumer (patient's father) reported for a 81-year-old male patient. A 81-year-old male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on 02Feb2021 as a single dose for covid-19 immunization. Caller reports her father had a previous diagnosis of Covid back in October2020, was hospitalized for about a week. Upon discharge he continued to feel fatigue with elevated D-dimer. Overall health declined. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received his first Pfizer Covid vaccine. That afternoon he experienced light headiness, chills, dizziness & fever, tired, loss of appetite and very weak on an unspecified date. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 80-year-old female patient who received Herpes zoster (Shingrix) (batch number 4XA55, expiry date 13th July 2023) for prophylaxis.   On 16th June 2022, the patient received the 1st dose of Shingrix. On 20th June 2022, 4 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 24-Jun-2022 Reporters comment: The patient received a dose of shingrix and experienced shingles outbreak. The reporter consented to follow up.
headache; Fatigue; Flu like symptoms; This is a spontaneous report from a non-contactable consumer.  A non-pregnant female patient of an unspecified age received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 28Jan2021 at a single dose for COVID-19 immunization; administered in a nursing home/senior living facility. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's medical history included allergy from an unknown date and unknown if ongoing (allergies to medications, food, or other products: yes). Concomitant medications were not reported. On 28Jan2021, the patient experienced headache (non-serious), fatigue (non-serious), and flu like symptoms (non-serious). There was no treatment received for the adverse events. The clinical course was reported as follows: The patient had a headache for the last four days (at the time of the report); which started about three hours after receiving the vaccine. The patient was also very fatigued and experienced flu like symptoms since receiving the vaccine. The patient underwent lab tests and procedures which included COVID test post vaccination: pending results on 02Feb2021. The clinical outcome of the events was not recovered.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Information has been received from a registered nurse concerning a 42 year-old white female patient with an allergy to amoxicillin and no other pertinent medical history, who on 26-Mar-2004 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck) (Lot#644570/1159M) and a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 648051/1350N) was administered on 14-May-2004. It was noted that an antibody titer drawn on 14-Jul-2004 had a negative result. The patient failed to seroconvert. It was also mentioned that the patient stated that she was exposed to chicken pox several times as a child and never got them. There was no product quality complaint reported.  Unspecified medical attention was sought.  No additional information is expected.
She experienced swelling of lymph nodes to left side of body, cough, paleness, and shortness of breath. Less than 24 hours after injection. She was seen in ER and it was determined she was having an allergic reaction.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age with no drug allergies. The patient's concurrent conditions and medical history were not reported. On 28-AUG-2014, the patient was vaccinated with a dose of ZOSTAVAX lot # J007208, expiration date: 20-SEP-2014 (also reported as 18-FEB-2015) 0.65 ml, subcutaneously, to prevent shingles. No concomitant medications were reported. The pharmacist reported, that on an unknown date after administration of ZOSTAVAX, the patient developed pain (unspecified location) and edema on his leg (unspecified leg). The patient was seen by an unspecified physician on an unspecified date, and was given ibuprofen to treat the pain. The pharmacist reported, that ibuprofen "only helped a little". The patient tried to use "alternative medicine like acupuncture" to relieve the edema but "it didn't help". The reporter also mentioned, that the patient was diagnosed with arthritis (date unknown). It was not known whether the diagnosis occurred before or after the patient received ZOSTAVAX. The outcome of the events was reported as not recovered/not resolved. The relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
This spontaneous report as received from a registered medical assistant refers to unknown number of patients of unknown age and gender. On an unknown date, the unknown number of patients were vaccinated with PNEUMOVAX 23. On an unknown date the patient may had received improperly storaged PNEUMOVAX 23. No adverse effects reported. This is one of several reports from the same source. Additional information is not expected.
Patient had an episode of syncope shortly after vaccine administration. Pulse dropped below 20 per nurses and amublance was called. Patient returned to normal vitals but continued having a panic attack for 30+ minutes
Patient called pharmacy 10 days after receiving vaccine to report that on her way home from clinic she experienced breathing difficulties, including in throat, pain on inspiration, and increasing feeling "whoozy".  Arm also became swollen and  painful  Patient did not seek medical attention but instead called  a friend and remained on the phone with her through the night, until symptoms resolved.
3/2/21 Received Gardasil 9, at first red, hard and getting bigger, about size of quarter, then itchy, no streaking, did cool compress and benadryl and itching went away, stopped getting bigger, still tender to touch, afebrile, no history of any reactions with immunizations.  On PE L upper arm with less than 1cm red bump on skin with less than 1cm induration, some tenderness to palpation.  Dx:  Hematoma.  Treatment:  Warm compress and massage may take weeks to months for resolution.
Red, swolle, warm and painful at injection site - 3-4 in" in diameter - x 24 hrs. Motrin-cool compress to site x 24 hrs.
MOP states patient had her 15/18 month immunizations on 9/30/2019, no other new exposures reported.   Vaccines received were DTaP #4 (SKB lot numbers CX59C left thigh, hepatitis A #2 lot #9 PE L5M mfx SKB, and HIB- PRP-OMP #3 Merck lot #S008729). She had no immediate reactions. Two days later, MOP noted a red raised area behind neck  in the morning followed by continued development  of urticarial lesions throughout the day to include her face, torso, extremities. The lesions were  extremely pruritic. She denies SOB, cough, wheezes, oral, face, throat, tongue swelling, flushing, watery eyes, conjunctivitis, rhinorrhea, cough emesis or diarrhea. She was seen the next day  and treated with benadryl, Zyrtec and both topical and oral steroid. The duration of symptoms was five days, then fully resolved and have not recurred.  Mom states she did have a mild reaction to 12 mo immunizations (MMR, varicella #1 & Prevnar #4) described as tiny erythematous papules  that lasted only hours .
I felt like I had a fever and so I just felt really bad June 17th morning. I took Motrin and OTC drugs. I didn't loose my appetite or have taste or smell issues. The next day I felt better. I was told not to work for 10 days and so I rested. I felt pretty good. I had a very mild case. I was put on Paxlovid right away for 5 days and I started it on Saturday afternoon.
This case was reported by a consumer and described the occurrence of injection site soreness in an adult female subject who was vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Approximately in 2007 the subject received unspecified dose of Influenza vaccine (unknown). In 2007, at an unspecified time after vaccination with Influenza vaccine, the subject experienced injection site soreness. At the time of reporting the outcome of the injection site soreness was unspecified. At the time of the report no other details were provided. The subject reported an adverse event with ENGERIX B; please see case A0977003A.
About 5 minutes after administration of the vaccination, patient became nauseated and was coughing a little, and had to lie down.  The patient's breathing was fine but he felt mostly nauseated which lasted for at least 30 minutes after he first told the staff he was nauseated.  We monitored patient while lying down, got a fan to put on him and after about 5 minutes of lying down, the patient sat back up in chair at immunization table and put a fan at table for him, he asked for water and some crackers which we gave him and he did eat and drink.  He texted his wife to come pick him up as we felt it may be unsafe for him to drive his 20 minute commute back home, his wife came approximately 40 - 45 minutes after his initial symptoms and by that time he was much better and walked out of the pharmacy area without assistance.
Twelve month old child work up with hives covering most of body along with inflammed joints on the knees, ankles, and wrists (Hot to touch).  Has continued off and on since that time.   Child had none of this prior to twelve month vaccinations. Child appears to be in pain due to this.
The day after the vaccine, I woke up feeling a sore throat and painful when swallowing. I went to an Urgent Care on 8/26/2021 and was diagnosed with tonsillitis. My tonsils were inflamed and the doctor said it was an immune response to the vaccine. I was instructed to rest, take Tylenol and the tonsilitis did resolve after 2 days. They also did Covid and strep test which were negative. I have an history of eczema and I have also noticed my eczema flared up after the first dose. It did resolve a week later. A week later, my period started on 8/30/2021 and the cramping was more severe than normal and I had to take a day off from work and take pain medication. I also noticed my menstrual flow was much heavier than normal the 1st 2 days.
1/27/2021-9:00pm- got chills and body ache 1/27/2021-11:00pm- got really hot, had fever of 100.3, body aches 1/28/2021-6:00am- no more fever,  more chills or hot feeling, but body was sore and achy  1/28/2021-3:30pm- all symptoms gone. No body pain, no fever, no discomfort besides mild arm pain at injection site.
No prior issues of anemia, on 16MAR my hb levels were 10.9. On 31MAR, my hb levels were 10.8. On 14APR, my hb level was at 10.5 and I was started on OTC iron supplement by my provider. On 2JUN, my hb level was at 12.3 and I was still diagnosed with iron deficient anemia.
3 hours post vaccine patient complained of chills and fatigue.  48 hours post vaccine patient developed a cough.
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Dec-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.            Concomitant drugs were not reported. Treatment medications were not provided.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 03/30/2021, 04/21/2021, and 12/11/2021. They were admitted to hospital on 06/24/2022 with  a primary complaint of shortness of breath. COVID-19 test on 06/24/2022 was negative. They were found to be experiencing complications of hypoxia and acute bilateral pulmonary thromboembolic tic disease. They were also diagnosed with mycoplasma pneumonia. A second test on 07/17/2022 was positive.  They were also diagnosed with COVID-19 pneumonia. They remained hospitalized until their death on 07/18/2022.
This spontaneous report was received from a healthcare administrator referring to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions and past drug reactions/allergies were not reported. Concomitant therapies included sterile diluent. On an unknown date, the patients were inadvertently vaccinated with improperly stored doses of VARIVAX lot # N031001 with expiration date: 03-NV-2019 (strength, dose, route and anatomical location were not provided) for prophylaxis. The temperature excursion occurred between 6° F and 14° F (5.8° F) with a time frame of 8 hours. The call was given by a data logger and there were no previous temperature excursions reported.
pt recv vax JAN97 & 3-4 wk later pt hosp for 2 days because stopped standing & would not walk;pt also had tremors;tests including spinal tap, blood count & viral studies were negative;
Hour after vaccine patient had vomited, vomited a 2nd time some time later, also feeling very fatigued. Advised family to continue monitoring symptoms and seek medical care if needed.
After injection on March14th 2021 on 15th March I felt chills and a little pain at injection site but not too bad.  On 16th March at 7:30 am I started to feel dizzy and out of balance and then suddenly my hearing in my right ear went and I had a sort of wind noise in my ear but no hearing. At approximately 1:00pmmy wife called our Doctor and he said that this could be a rare side effect of the Covid Vaccine and to allow up to 24 hours for the effect to resolve itself. By 4:00pm.the effect did resolve itself but returned at 10:00amon 18th March and lasted for 4 hours. Since then I have been OK with no further effects.